The effectiveness of the innovative drug “Regasthym Gastro” (alpha-glutamyl tryptophan) in the complex treatment of chronic atrophic gastritis-Reference-Cited by-同舟云学术

The effectiveness of the innovative drug “Regasthym Gastro” (alpha-glutamyl tryptophan) in the complex treatment of chronic atrophic gastritis

Published:2023-10-09 Issue:8 Volume: Page:100-102
ISSN:1682-8658
Container-title:Experimental and Clinical Gastroenterology
language:
Short-container-title:jour

Author:

Uspensky Yu. P.¹^ORCID,Baryshnikova N. V.²^ORCID,Fominykh Yu. A.¹^ORCID,Ivanov S. V.¹^ORCID,Gnutov A. A.³^ORCID,Gulunov Z. Kh.³^ORCID,Sousova Ya. V.¹^ORCID,Krasnov A. A.⁴^ORCID,Apryatina V. A.⁵^ORCID,Petlenko S. V.⁶^ORCID

Affiliation:

1. Saint- Petersburg State Pediatric Medical University; Pavlov First Saint Petersburg State Medical University

2. Saint- Petersburg State Pediatric Medical University; Pavlov First Saint Petersburg State Medical University; Institute of experimental medicine

3. Saint- Petersburg State Pediatric Medical University

4. The Herzen State Pedagogical University of Russia

5. Institute of translational biomedicine

6. Golikov Research Clinical Center of Toxicology under the Federal Medical-Biological Agency

Abstract

Publisher

LLC Global Media Technology

Subject

Gastroenterology,Hepatology

Reference10 articles.

1. The use of alpha-glutamyl-tryptophan for the prevention of stomach cancer in patients with chronic atrophic gastritis. Guidelines approved by the Health Committee of St. Petersburg. St. Petersburg, 2022. 40 P. (in Russ.)@@ Ispol'zovanie al'fa-glutamil-triptofana dlya profilaktiki raka zheludka u patsientov s khronicheskim atroficheskim gastritom. Metodicheskie rekomendatsii, utverzhdennye Komitetom po Zdravookhraneniyu Sankt-Peterburga. SPb, 2022. - 40 s.

2. Ohashi H., Maruyama T., Higashi-Matsumoto H., Nomoto T., Nishimura S., Takeuchi Y. A novel binding assay for metabotropic glutamate receptors using [3H] L-quisqualic acid and recombinant receptors. Z Naturforsch C J Biosci. 2002;57(3-4):348-55. doi: 10.1515/znc-2002-3-425.

3. Shevtsov M.A., Smagina L. V., Kudriavtceva T. A., Petlenko S. V., Voronkina I. V. Glu-Trp-ONa or its acylated analogue (R-Glu-Trp-ONa) administration enhances the wound healing in the model of chronic skin wounds in rabbits. Drug Des Devel Ther. 2015;9:1717-27. doi: 10.2147/DDDT.S79665.

4. Petlenko I.S., Egorova T. Yu., Petlenko S. V. et al. Experimental study of the specific activity of L-Glutamyl- L-Tryptophan. Modern problems of science and education. 2019; 3 (in Russ.) (available at: https://science-education.ru/ru/article/view?id=28988&ysclid=lg4ut60640101254054 (accessed 06.04.2023)@@ Petlenko I. S., Egorova T. Yu., Petlenko S. V. i dr. Eksperimental'noe izuchenie spetsificheskoi aktivnosti L-Glutamil - L-Triptofana. Sovremennye problemy nauki i obrazovaniya. 2019; 3 [elektronnyi resurs]. URL: https://science-education.ru/ru/article/view?id=28988&ysclid=lg4ut60640101254054 (data obrashcheniya 06.04.2023)

5. Petlenko S.V., Golovacheva E. G., Afanasieva O. I. Opportunities for immunocorrection aiming for reduction of morbidity in the areas with adverse occupational and environmental conditions. Medical Immunology. 2020; 22 (6): 1097-1110. (in Russ.) doi:10.15789/1563-0625-OFI-2055.@@ Petlenko S. V., Golovacheva E. G., Afanas'eva O. I. Vozmozhnosti immunokorrektsii dlya snizheniya urovnya zabolevaemosti lyudei v raionakh s neblagopriyatnymi professinal'nymi i ekologicheskimi faktorami. Meditsinskaya immunologiya. 2020; 22 (6): 1097-1110. doi:10.15789/1563-0625-OFI-2055.